GALT
Galectin Therapeutics IncCompany with tickers: GALT
CIK
1133416
CUSIP
363225202
Shares Outstanding
65,856,898
13F Activity (30d)
82 filings
80 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-02-20 | 2020-02-19 | |
| 10-K | 2020-03-16 | 2019-12-31 | |
| 8-K | 2020-03-16 | — | |
| 8-K | 2020-03-17 | 2020-03-12 | |
| 8-K | 2020-04-30 | — | |
| 10-Q | 2020-05-11 | 2020-03-31 | |
| 8-K | 2020-05-11 | — | |
| 8-K | 2020-06-26 | 2020-06-22 | |
| 8-K | 2020-06-30 | — | |
| 8-K | 2020-08-10 | — | |
| 10-Q | 2020-08-10 | 2020-06-30 | |
| 8-K | 2020-09-02 | 2020-08-31 | |
| 8-K | 2020-09-22 | — | |
| 8-K | 2020-09-29 | — | |
| 8-K | 2020-11-09 | — | |
| 10-Q | 2020-11-09 | 2020-09-30 | |
| 8-K | 2020-12-03 | — | |
| 8-K | 2020-12-07 | 2020-12-03 | |
| 8-K | 2021-03-09 | — | |
| 10-K | 2021-03-31 | 2020-12-31 | |
| 8-K | 2021-03-31 | — | |
| 8-K | 2021-04-19 | 2021-04-16 | |
| 10-Q | 2021-05-17 | 2021-03-31 | |
| 8-K | 2021-05-17 | — | |
| 8-K | 2021-07-09 | — | |
| 8-K | 2021-07-26 | — | |
| 8-K | 2021-08-16 | — | |
| 10-Q | 2021-08-16 | 2021-06-30 | |
| 8-K | 2021-09-13 | — | |
| 8-K | 2021-09-21 | 2021-09-17 | |
| 8-K | 2021-11-15 | — | |
| 10-Q | 2021-11-15 | 2021-09-30 | |
| 8-K | 2021-12-03 | — | |
| 8-K | 2021-12-07 | 2021-12-03 | |
| 8-K | 2021-12-21 | 2021-12-20 | |
| 8-K | 2022-03-31 | — | |
| 10-K | 2022-03-31 | 2021-12-31 | |
| 8-K | 2022-04-14 | — | |
| 8-K | 2022-05-16 | — | |
| 10-Q | 2022-05-16 | 2022-03-31 | |
| 8-K | 2022-07-26 | 2022-07-25 | |
| 8-K | 2022-08-15 | — | |
| 10-Q | 2022-08-15 | 2022-06-30 | |
| 8-K | 2022-10-06 | — | |
| 8-K | 2022-10-12 | — | |
| 10-Q | 2022-11-14 | 2022-09-30 | |
| 8-K | 2022-11-14 | — | |
| 8-K | 2022-12-01 | — | |
| 8-K | 2022-12-06 | 2022-12-01 | |
| 8-K | 2023-01-05 | — |
Showing 1–50 of 101 filings